Renpho
Renpho

Investment

Leading NAD+ company ChromaDex announces $25m raise

LA-based company ChromaDex announces that it has entered into a securities purchase agreement for the sale of $25m of...

Andreessen Horowitz leads $7m seed funding: Bold

Digital health and wellness company bags $7 million in seed funding led by Andreessen Horowitz. Bold focuses on disease prevention and healthy aging. Using personalised and...

Charles River to acquire Cognate BioServices for $875m

Charles River Laboratories signs $875 million cash deal to acquire cell and gene manufacturer Cognate BioServices. Charles River has announced plans to acquire Cognate BioServices,...

Latest news

$1.1B biotech SPAC good news for longevity

Bioengineered human tissue company Humacyte nears biotech SPAC deal to go public. Humacyte, a transformative biotech platform company capable of manufacturing universally-implantable bioengineered human tissue...

The trillion dollar upside to longevity

New economic model estimates that targeting aging has larger economic gains than eradicating individual diseases: time for a policy pivot? Although life expectancy has increased...

Biophytis closes $20m capital raise on NASDAQ

Paris and Cambridge, Massachusetts-based biotech closes $20.1 million in gross proceeds. Clinical-stage biotech Biophytis today announced the closing of its IPO on the Nasdaq Capital...

International Day of Women and Girls in Science

As we celebrate International Day of Women and Girls in Science, here are just a few of the names to be found in our...

Longevity investing has “come of age” says MMC founder

McKenny-McFarlane Capital is focused on bridging the communication gap between longevity investing and longevity companies. An investment firm with its sights firmly locked on longevity...

Longevity Card launches £415k crowdfunding campaign

Longevity focused FinTech launches equity crowdfunding campaign on Seedrs with 60% of target already reached. UK-based FinTech company Longevity Card has today launched a crowdfunding...

Open Life secures funding for longer, healthier lives

Open Life data project secures funding to help UK develop pandemic resilience and promote healthy life extension. The All Party-Parliamentary Group (APPG) for Longevity has...

Cambrian Biopharma exits stealth with $60m and affiliate IPO

New York-based biotech raises $60 million to develop a pipeline of companies and therapeutics to treat diseases of aging under its unique operational strategy. Cambrian...

British biotech success is longevity confidence boost

UK business confidence is at six-year high as biotech innovation and vaccine success dispel lockdown gloom. Data from IHS Markit demonstrates that British business confidence...
Renpho
Longevity.Technology welcome banner

Longevity “top of my agenda” says Silicon Valley Bank VP

Flavia Popescu-Richardson talks longevity investment and how venture debt financing can benefit early stage companies. The longevity sector is expanding with early-stage companies and, although...

2021 hits the longevity ground running

Highlights from longevity research, trials and funding in January 2021 Hundreds of companies are working to develop treatments to slow down aging and increase healthy...

Cellino closes $16m seed financing

Massachusetts-based biotech announces closing of $16m seed round led by The Engine and Khosla Ventures. Cellino has raised $16 million in seed venture capital in...

Biotech Longeveron files for $30M IPO

Florida-based Longeveron files for a $30 million IPO, targeting aging-related conditions. Longeveron, a Phase 2 biotech which develops cellular therapies for aging-related conditions, filed the...

Most popular

Cambrian Biopharma exits stealth with $60m and affiliate IPO

New York-based biotech raises $60 million to develop a pipeline of companies and therapeutics to treat diseases of aging under its unique operational strategy. Cambrian...

Longevity companies to watch in 2021

As the world enters the new year with a vaccine and an increased focus on geroprotection, there’s much to look forward to. Research from the...

$1.1B biotech SPAC good news for longevity

Bioengineered human tissue company Humacyte nears biotech SPAC deal to go public. Humacyte, a transformative biotech platform company capable of manufacturing universally-implantable bioengineered human tissue...

Leading NAD+ company ChromaDex announces $25m raise

LA-based company ChromaDex announces that it has entered into a securities purchase agreement for the sale of $25m of its common stock in a...
Apollo Neuro

You might also like

The Sheekey Science Show: NAD+ rejuvenation strategies

NAD+ metabolism in aging & three strategies to rejuvenate. Welcome to The Sheekey Science Show! Longevity.Technology is delighted to partner with YouTube sensation Eleanor Sheekey (interviewed...

JUVICELL sets sights on lifespan and healthspan

Ten ingredients, one capsule. JUVICELL is on a mission to deliver an all-in-one longevity supplement. Far from just supplementing their diet to ensure an adequate...

New NAD+ boosting longevity supplement hits the market

Elevant Prime dietary supplement contains a “high purity” form of NMN that has completed safety and toxicology testing. New York based health and wellness brand...

BioAge kicks off Phase 2 longevity clinical trial

Company reveals primary indicator for BGE-117 clinical trial is unexplained anaemia of aging. Hot on the heels of its monster $90 million Series C funding...

Review: Sensate

You’ve heard of the Rock, well this is the pebble! Our intrepid reviewer spent 30 days using the Sensate 2 device and here is...
TruNigen pf